n(1)-methylnicotinamide has been researched along with Uterine Cervical Dysplasia in 1 studies
N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.
Uterine Cervical Dysplasia: Abnormal development of immature squamous EPITHELIAL CELLS of the UTERINE CERVIX, a term used to describe premalignant cytological changes in the cervical EPITHELIUM. These atypical cells do not penetrate the epithelial BASEMENT MEMBRANE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Furthermore, the level of me-NAM in cervical cancer tissues of stage I, II, III, and IV was higher than that of those without lymph node metastasis." | 1.62 | Diagnostic Value of Serum N1-Methylnicotinamide in Cervical Cancer Patients. ( Ji, M; Lin, S; Na, N, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, M | 1 |
| Na, N | 1 |
| Lin, S | 1 |
1 other study available for n(1)-methylnicotinamide and Uterine Cervical Dysplasia
| Article | Year |
|---|---|
Diagnostic Value of Serum N1-Methylnicotinamide in Cervical Cancer Patients.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; Female; Humans; Lymphatic Metastasis; Niacinamide; Prognosis; | 2021 |